Back to News
³Ô¹Ï±¬ÁÏ AI Agents to Be Released Across All ³Ô¹Ï±¬ÁÏ Applications
Deep, industry-specific agents planned for availability starting this December
PLEASANTON, CA ¡ª October 14, 2025 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) today announced ³Ô¹Ï±¬ÁÏ AI Agents are planned for availability starting December 2025 for commercial and across R&D and quality in 2026. ³Ô¹Ï±¬ÁÏ AI adds agentic AI to the ³Ô¹Ï±¬ÁÏ Vault Platform and deep, industry-specific agents for ³Ô¹Ï±¬ÁÏ applications in all major areas, including clinical, regulatory, safety, quality, medical, and commercial.
Designed for specific, high-impact use cases, ³Ô¹Ï±¬ÁÏ AI Agents understand the ³Ô¹Ï±¬ÁÏ application context, have application-specific prompts and safeguards, and have direct, secure access to ³Ô¹Ï±¬ÁÏ application data, documents, and workflows. Because ³Ô¹Ï±¬ÁÏ AI is built into the ³Ô¹Ï±¬ÁÏ Vault Platform, customers can also configure and extend ³Ô¹Ï±¬ÁÏ-delivered AI Agents and build their own custom agents.
Planned Availability of ³Ô¹Ï±¬ÁÏ AI Agents by Area
- December 2025 Vault CRM, PromoMats
- April 2026 Safety, Quality
- August 2026 Clinical Operations, Regulatory, Medical
- December 2026 Clinical Data
³Ô¹Ï±¬ÁÏ AI Agents use large language models (LLMs) from Anthropic and Amazon, hosted on Amazon Bedrock. Custom agents created with ³Ô¹Ï±¬ÁÏ AI use ³Ô¹Ï±¬ÁÏ-hosted models or customer provided models hosted on Amazon Bedrock or Microsoft Azure AI Foundry. ³Ô¹Ï±¬ÁÏ AI¡¯s usage-based pricing makes it easier for customers to get started and scale over time.
¡°AI will fundamentally change how drugs are developed and how treatment decisions are made at the point of care,¡± said ³Ô¹Ï±¬ÁÏ CEO Peter Gassner. ¡°Our goal with ³Ô¹Ï±¬ÁÏ AI is to help the industry greatly increase innovation and productivity so better medicines reach more patients, faster.¡±
For more information and updates, customers can visit the on ³Ô¹Ï±¬ÁÏ Connect.
About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world¡¯s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
³Ô¹Ï±¬ÁÏ Forward-Looking Statements
This release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ¡¯s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2025, which you can find (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at .
###
Contact:
Maria Scurry
³Ô¹Ï±¬ÁÏ Systems
781-366-7617
maria.scurry@veeva.com